VCU Massey Cancer Center continues to test new technology by ApoCell, Inc. that can detect circulating tumor cells (CTC) in a patient’s bloodstream. In April, Massey reported on a pilot study of the device in liver cancer patients, and now … Continue reading
New technology from ApoCell, Inc. that can detect liver cancer cells circulating in a patient’s bloodstream may remove the need for potentially dangerous liver biopsies, be used as a screening tool and, ultimately, speed up drug development, according to a … Continue reading
Virginia Commonwealth University Massey Cancer Center opened a Phase II clinical study to see whether an FDA-cleared pain therapy device helps decrease pain in cancer patients. The study will examine the device’s effect on pain associated with chemotherapy-induced peripheral neuropathy … Continue reading
Fairfield, CT and Richmond, VA – (May 26, 2009) – Competitive Technologies, Inc. (NYSE Amex: CTT) announced today that CTT’s pain therapy medical device will be used by clinical investigators at the Virginia Commonwealth University Massey Cancer Center for a … Continue reading
VCU Massey Cancer Center Researcher Authors Study on Data Collected by 1,300 Cancer Centers for the Journal of Nuclear Medicine Richmond, Va. (Dec. 9, 2008)–With the most recent release of data from the National Oncologic PET Registry (NOPR), researchers may … Continue reading